International Journal of Medical and Dental Sciences

Open Access Open Access  Restricted Access Subscription Access

Epidermal Growth Factor and Diabetes Mellitus;Friends or Faux?


Affiliations
1 Department of Dentistry, The British University, Cairo, Egypt
2 Department of Dentistry, October University for Modern Sciences and Arts, Cairo, Egypt
3 School of Dentistry and Oral Health, Griffith University, Queensland, 4222, Australia
 

Diabetes being the most common chronic metabolic disorder has a number of complications that affect various parts of the body. Epidermal growth factor (EGF) is well known for its healing capacity. In this article we review the two way relationship between diabetes and EGF, where the former needs to block the latter's secretion and reduce its expression on order to produce its notorious complications. On the contrary, the latter is capable of reversing the former's negative adverse effect on various organs of the body. We also shed some light on different studies in the literature that investigated the role of EGF in the dynamics of diabetes, and gain a deeper insight towards the possible applications of local and systemic treatment with EGF in the management of diabetic complications. We also try to answer some questions: EGF and diabetes; Friends or faux? and will EGF be the future trend in reversing damage caused by diabetes and wound healing?.

Keywords

Submandibular Salivary Gland, Epidermal Growth Factor, Diabetes, Streptozotocin, Wound Healing.
User
Notifications
Font Size


  • Keswani SG, Balaji S, Le LD, Leung A, Parvadia JK, Frischer J, et al. Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair Regen 2013;21(4):554-62.

  • Venturi S, Venturi M. Iodine in evolution of salivary glands and in oral health. Nutrition and Health 2009;20(2):119-134.

  • Herbst RS. Review of epidermal growth factor receptor biology. International Journal of Radiation Oncology, Biology, Physics 2004;59(2):21-26.

  • Wei F, Lin CC, Joon A, Feng Z, Troche G, Lira ME, et al. Non-invasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med 2014; 190(10):1117-26.

  • Tiaka EK, Papanas N, Manolakis AC, Georgiadis GS. Epidermal growth factor in the treatment of diabetic foot ulcers: an update. Perspect Vasc Surg Endovasc Ther 2012; 24(1):37-44.

  • Noguchi S, Ohba Y, Oka T. Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol 1991;260(4):E620-625.

  • Hong JP, Lee SW, Song SY, Ahn SD, Shin SS, Choi EK, et al. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies. Eur J Cancer Care (Engl) 2009;18(6):636-641.

  • Marcinkiewicz M, Grabowska SZ, Czyzewska E. Role of epidermal growth factor (EGF) in oesophageal mucosal integrity.Curr Med Res Opin 1998;14(3):145-153.

  • Geng Y, Li J, Wang F, Li Q, Wang X, Sun L, et al. Epidermal Growth Factor Promotes Proliferation and Improves Restoration After Intestinal Ischemia–Reperfusion Injury in Rats. Inflammation 2013;36:670-679.

  • Adamek B, Zalewska-Ziob M, Strzelczyk J, Spausta G, Kasperczyk J, Wiczkowski A, et al. Does epidermal growth factor effect on late stages of rat liver regeneration upon interferon a2b influence? E&C Hepatology 2011;7(1):29-33.

  • Nagy A, Nagashima H, Cha S, Oxford GE, Zelles T, Peck AB, et al. Reduced Oral Wound Healing in the NOD Mouse Model for Type 1 Autoimmune Diabetes and Its Reversal by Epidermal Growth Factor Supplementation. Diabetes 2001;50(9):2100-2104.

  • Li ZW, Li JJ, Wang L, Zhang JP, Wu JJ, Mao XQ, et al. Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J Neuroinflammation 2014;5(11):71.

  • Lee HY, Yea K, Kim J, Lee BD, Chae YC, Kim HS, et al. Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice. J Cell Mol Med 2008; 12(5A):1593-1604.

  • Kashimata M, Hiramatsu M, Minami N, Sato A, Minami N. Effect of experimental diabetes on epidermal growth factor (EGF) receptors in the rat liver. Nihon Yakurigaku Zasshi 1987;89:253-259.

  • Kasayama S, Yoshimura M, Oka T. Decreased expression of hepatic epidermal growth factor receptor gene in diabetic mice. J Mol Endocrinol 1989;3(1):49-56.

  • Kasayama S, Ohba Y, Oka T. Epidermal growth factor deficiency associated with diabetes mellitus. Proc Natl Acad Sci USA 1989;86(19):7644-7648.

  • Oxford GE, Tayari L, Barfoot MD, Peck AB, Tanaka Y, Humphreys-Beher MG. Salivary EGF levels reduced in diabetic patients. J Diabetes Complications 2000;14(3):140-145.

  • Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY, et al. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 2003;26(6):1856-1861.

  • Singla S, Garg R, Kumar A, Gill C. Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: Comparative analysis of 50 patients. J Nat Sci Biol Med 2014;5:273-277.

  • Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg.2006;56(4):394-398.

  • Singla S, Singla S, Kumar A, Singla M. Role of epidermal growth factor in healing of diabetic foot ulcers. Indian J Surg 2012;74(6):451-455.

  • Zong S, Liang S, Ou B. Effect of topical external administration of recombinant human epidermal growth factor on expression of epidermal growth factor receptor and its mRNA in scald wound of diabetes mellitus rat. Chinese Journal of Reparative and Reconstructive Surgery 2010;24(2):150-155.

  • Lao G, Yan L, Yang C, Zhang L, Zhang S, Zhou Y. Controlled Release of Epidermal Growth Factor from Hydrogels Accelerates Wound Healing in Diabetic Rats. J Am Podiatr Med Assoc 2012;102(2):89-98.

  • Akhtar S, Almubrad T, Bron AJ, Yousif MHM, Benter IF, Akhtar S. Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes. Acta Ophthalmol 2009;87(8):881-889.

  • Akhtar S, Benter IF. The Role of Epidermal Growth Factor Receptor in DiabetesInduced Cardiac Dysfunction. BioImpacts 2013;3(1):5-9.


Abstract Views: 190

PDF Views: 110




  • Epidermal Growth Factor and Diabetes Mellitus;Friends or Faux?

Abstract Views: 190  |  PDF Views: 110

Authors

M. M. Al-Ankily
Department of Dentistry, The British University, Cairo, Egypt
M. Shamel
Department of Dentistry, October University for Modern Sciences and Arts, Cairo, Egypt
M. M. Bakr
School of Dentistry and Oral Health, Griffith University, Queensland, 4222, Australia

Abstract


Diabetes being the most common chronic metabolic disorder has a number of complications that affect various parts of the body. Epidermal growth factor (EGF) is well known for its healing capacity. In this article we review the two way relationship between diabetes and EGF, where the former needs to block the latter's secretion and reduce its expression on order to produce its notorious complications. On the contrary, the latter is capable of reversing the former's negative adverse effect on various organs of the body. We also shed some light on different studies in the literature that investigated the role of EGF in the dynamics of diabetes, and gain a deeper insight towards the possible applications of local and systemic treatment with EGF in the management of diabetic complications. We also try to answer some questions: EGF and diabetes; Friends or faux? and will EGF be the future trend in reversing damage caused by diabetes and wound healing?.

Keywords


Submandibular Salivary Gland, Epidermal Growth Factor, Diabetes, Streptozotocin, Wound Healing.

References





DOI: https://doi.org/10.18311/ijmds%2F2016%2F100625